NCT03634202 2019-05-15
DESIR
Institut Cancerologie de l'Ouest
Phase NA Terminated
Clinical Trials
4 trialsNCT01841021 2017-01-19
Pilot Study of Brentuximab Vedotin in Relapsed/Refractory Peripheral T-Cell Lymphoma Expressing CD30
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Terminated
NCT01760694 2014-08-15
Multi-Modality Therapy for Untreated Patients With Resectable or Marginally Resectable Pancreatic Cancer
Southwestern Regional Medical Center
Phase NA Terminated
NCT01056809 2012-05-31
PGC
Vrinnevi Hospital
Phase NA Terminated